双極性I型障害におけるBW430C（ラモトリギン）の臨床評価 - 試験SCA104779の長期延長（NCT00550407） -
基本情報
- NCT ID
- NCT00566020
- ステータス
- 完了
- 試験のフェーズ
- 第3相
- 試験タイプ
- 介入
- 目標被験者数
- 92
- 治験依頼者名
- GlaxoSmithKline
概要
This study is planned to assess the long-term safety of lamotrigine in Japanese patients with bipolar I disorder who will continue into the 52-week extension upon completion of a double-blind comparative study (Study No.: SCA104779 (NCT00550407)), i.e. the patients who receive the addition of any additional treatment to intervene in a mood episode in the double-blind phase or the patients completing the double-blind phase.
対象疾患
介入
依頼者（Sponsor）
実施施設 (50)
GSK Investigational Site
Gunma, Japan
独立行政法人国立病院機構水戸医療センター
Ibaraki, Japan
GSK Investigational Site
Hiroshima, Japan
GSK Investigational Site
Kanagawa, Japan
GSK Investigational Site
Mie, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tottori, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Ōita, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Kanagawa, Japan
国立研究開発法人国立国際医療研究センター 国府台病院
Chiba, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Hiroshima, Japan
GSK Investigational Site
Mie, Japan
独立行政法人国立病院機構 肥前精神医療センター
Saga, Japan
GSK Investigational Site
Yamagata, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Kyoto, Japan
GSK Investigational Site
Kumamoto, Japan
GSK Investigational Site
Fukuoka, Japan
九州大学病院
Fukuoka, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Ōita, Japan
GSK Investigational Site
Chiba, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Hokkaido, Japan
GSK Investigational Site
Osaka, Japan
GSK Investigational Site
Tokyo, Japan
GSK Investigational Site
Kanagawa, Japan
GSK Investigational Site
Tokyo, Japan
昭和大学横浜市北部病院
Kanagawa, Japan
GSK Investigational Site
Aichi, Japan
GSK Investigational Site
Hokkaido, Japan
GSK Investigational Site
Fukuoka, Japan
GSK Investigational Site
Saitama, Japan
公立大学法人 奈良県立医科大学附属病院
Nara, Japan
日本医科大学付属病院
Tokyo, Japan
北海道大学病院
Hokkaido, Japan
千葉大学医学部附属病院
Chiba, Japan
GSK Investigational Site
Gunma, Japan
GSK Investigational Site
Ōita, Japan
岡山大学病院
Okayama, Japan
GSK Investigational Site
Kanagawa, Japan
GSK Investigational Site
Kanagawa, Japan